Pharmacognosy intro
Taraxacum officinale F.H. Wigg. (Asteraceae) is a perennial herb of near-global distribution, one of the most extensively studied and universally available medicinal plants. The root contains a complex mixture of sesquiterpene lactones (taraxacin and taraxacerin, responsible for the characteristic bitter latex), triterpene alcohols (taraxasterol, taraxerol, beta-amyrin), phytosterols (beta-sitosterol, stigmasterol), phenolic acids (caffeic acid, chlorogenic acid, p-hydroxyphenylacetic acid), and the polysaccharide inulin (constituting up to 40% of mature autumn root dry weight). The leaf is notably rich in potassium (approximately 4.5% dry weight), vitamins A and C (exceeding concentrations in most cultivated vegetables), and flavonoids including luteolin and luteolin-7-glucoside. The hepatoprotective mechanism of dandelion root operates through multiple converging pathways. Taraxasterol, the principal triterpene, has demonstrated anti-inflammatory activity via inhibition of the NF-kB and MAPK signaling pathways, reducing nitric oxide, prostaglandin E2, and proinflammatory cytokine production in LPS-stimulated RAW 264.7 macrophages. The root extract elevates antioxidant potentials (superoxide dismutase, catalase, glutathione peroxidase) while decreasing lipid peroxidation markers in alcohol-induced and CCl4-induced hepatotoxicity models. The leaf fraction exerts potent diuretic activity comparable to furosemide in animal models, but with a critical distinction: the high potassium content of the leaf naturally replenishes the potassium lost through increased urination, avoiding the hypokalemic risk inherent in pharmaceutical diuretics. The root additionally exhibits choleretic activity (increased bile production and flow), supporting phase II hepatic detoxification. Taraxacum officinale holds GRAS (Generally Recognized As Safe) status from the US FDA and approval from the Council of Europe for food use. It has been employed in traditional Chinese medicine for over a thousand years for liver and breast conditions. The British Herbal Pharmacopoeia lists it for cholecystitis, gallstones, jaundice, and atonic dyspepsia. The German Commission E approved dandelion root for disturbances of bile flow and as a diuretic, and dandelion herb (leaf) for loss of appetite and dyspepsia. Pharmacokinetic studies of taraxasterol in rats show oral bioavailability with Cmax of 323 ng/mL after 7.75 mg/kg dosing and a half-life of approximately 0.83 hours.